Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.
When patients and physicians disagree on the use of genetic engineering technology, physicians must act in accordance with professional ethics and society's guidelines.
Genetic information is redefining what society and the medical profession considers to be normal and what departures from the norm are deserving of medical intervention.
An ethical case explores whether a workplace physician breached patient confidentiality by divulging an employee's medical information to the employer.